The Clinical Efficacy of Different Durations of Suprascapular Nerve Pulsed Radiofrequency

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorAnkara University

About this trial

Chronic shoulder pain due to impingement syndrome and supraspinatus tendinosis is a debilitating condition. Suprascapular nerve innervates most part of shoulder joint. Supraspinatus nerve block can be used as a part of pain therapy. However, its efficacy is short-lasting. To prolong analgesia, short bursts of electrical stimulation to suprascapular nerve may be applied. To the date there is no consensus about duration of these type of stimulation. Investigators' aim is to investigate efficacy of two different duration of stimulation (pulsed radiofrequency) on chronic shoulder pain.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged 18-80 years

Shoulder pain caused by impingement syndrome

Shoulder pain due to supraspinatus tendinosis

Diagnosis of impingement syndrome and supraspinatus tendinosis confirmed through physical examination and radiological imaging (MRI)

Disqualifiers

Patients unwilling to participate in the study

Presence of chronic pain due to other conditions

Presence of cervical radiculopathy

History of opioid use

Trial design

Design model

Parallel

Treatments tested in this trial

  • suprascapular nerve block and 4 mins Pulsed radiofreuency application to suprascapular nerve

    Procedure/Surgery

    suprascapular nerve pulsed rf

  • suprascapular nerve block and 9 mins Pulsed radiofreuency application to suprascapular nerve

    Procedure/Surgery

    suprascapular nerve block and 4 mins Pulsed radiofreuency application to suprascapular nerve

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: 4 min suprascapular pulsed RFOther 1 intervention
Group B: 9 min suprascapular pulsed RFOther 1 intervention

Trial outcomes

Primary outcomes

1

Postprocedure 3th month pain severity

Severity of pain will be assessed with Numeric Rating Scale (NRS-11) at baseline, 1 weeks, 1 months and 3 months after interventions. NRS-11 is a 11 point likert type scale. Higher scores represent more severe pain.

Time frame
From procedure to 3 months after prodecure

Secondary outcomes

1

Postprocedure pain severity at first week

Severity of pain will be assessed with Numeric Rating Scale (NRS-11) at 1 week after interventions. NRS-11 is a 11 point likert type scale. Higher scores represent more severe pain.

Time frame
From procedure to 1 week after procedure
2

Postprocedure first month pain severity

Severity of pain will be assessed with Numeric Rating Scale (NRS-11) at 1 month after interventions. NRS-11 is a 11 point likert type scale. Higher scores represent more severe pain.

Time frame
From procedure to 1 month after procedure
3

Postprocedure SPADI scores at first week

Functionality will be assessed with Shoulder Pain and Disability Index (SPADI) at 1 week. SPADI measures pain and disability related shoulder function. SPADI has 0 minimum and 100 maximum value. Lower scores represent better outcomes.

Time frame
From procedure to 1 week after procedure
4

Postprocedure first month SPADI scores

Functionality will be assessed with Shoulder Pain and Disability Index (SPADI) at 1 month. SPADI measures pain and disability related shoulder function. SPADI has 0 minimum and 100 maximum value. Lower scores represent better outcomes.

Time frame
From procedure to 1 month after procedure

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: